[1]
L. Dong, H. xu, X. Pang, Y. Liu, and M. Li, “Advances in immunotherapy for HNSCC”, Serican J. Med., vol. 2, no. 1, Jan. 2025, doi: 10.17161/sjm.v2i1.23137.